Log In
BCIQ
Print this Print this
 

ProscaVax

  Manage Alerts
Collapse Summary General Information
Company OncBioMune Pharmaceuticals Inc.
DescriptionProstate cancer vaccine containing prostate-specific antigen (KLK3; PSA), IL-2 and GM-CSF
Molecular Target
Mechanism of ActionImmunotherapy
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationProstate cancer
Indication DetailsTreat prostate cancer; Treat recurrent prostate cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/29/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today